Farid Takes Helm of Aurion MAB - Scorecard - MDSpire

Farid Takes Helm of Aurion MAB

Aurion Biotech names Marjan Farid chair of medical advisory board

  • March 27, 2026

  • 2 min

Share

Clinical Scorecard: Farid Takes Helm of Aurion MAB

At a Glance

CategoryDetail
ConditionCorneal Endothelial Disease
Key MechanismsProgressive vision loss due to corneal endothelial dysfunction
Target PopulationPatients with corneal endothelial disease, affecting millions globally
Care SettingClinical settings specializing in ophthalmology and regenerative therapies

Key Highlights

  • Marjan Farid appointed as chair of Aurion's medical advisory board
  • Aurion developing AURN001, an investigational allogeneic cell therapy
  • Vyznova launched as the first commercially available cell therapy for corneal endothelial disease
  • Farid recognized for advancing patient care and innovation in corneal treatments
  • Aurion aims to transform corneal care in the United States

Guideline-Based Recommendations

Diagnosis

  • Assessment of corneal endothelial function and vision loss

Management

  • Consider investigational therapies like AURN001 for eligible patients

Monitoring & Follow-up

  • Regular follow-up on visual acuity and corneal health

Risks

  • Potential for progressive vision loss if untreated

Patient & Prescribing Data

Individuals diagnosed with corneal endothelial disease

Emerging therapies may offer new hope for vision restoration

Clinical Best Practices

  • Integrate advanced treatment options for corneal diseases
  • Stay updated on clinical trials and emerging therapies
  • Collaborate with specialized centers for complex cases

References

Original Source(s)

Farid Takes Helm of Aurion MAB

  • March 27, 2026

Related Content

Integrating EyeCare

As demand for ophthalmic services surges, EyeCare Partners is building a physician-led network designed to meet rising clinical and research needs

  • April 20, 2026

  • 10 min
Letter From the Editor: IOLs in Refractive Cataract Surgery

In this issue of The Ophthalmic ASC, we interview several surgeons to discover what is in their IOL closets. It is fun to see what some of the top surgeons in the country use as their favorite IOLs and the different ASC inventory management solutions that can help make this possible!  

Eye on OOSS: Advocacy Matters, and It Works

In an increasingly complex health care environment, the combination of strong advocacy, collaborative learning, and access to actionable resources, positions OOSS members for continued success.